(Q40922844)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

A gene deletion that up-regulates viral gene expression yields an attenuated RSV vaccine with improved antibody responses in children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

1 reference

1

Ruth A Karron

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

5

Janet A Englund

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Cindy Luongo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Bhagvanji Thumar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Karen M Loehr

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Peter L Collins

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Ursula J Buchholz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

1 November 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

Science Translational Medicine

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

312ra175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

The burden of respiratory syncytial virus infection in young children

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for va

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Risk of primary infection and reinfection with respiratory syncytial virus

21 January 2018

2 references

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/26537255

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAC8463

Live-attenuated respiratory syncytial virus vaccines

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26537255

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Challenges and opportunities for respiratory syncytial virus vaccines

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26537255

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1126/SCITRANSLMED.AAC8463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537255%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

26537255

1 reference